Lupus Science and Medicine podcast by BMJ talk medicine published on 2013-10-24T08:52:12Z From June 2023, all our podcasts will move to https://lupusbmj.podbean.com. You can continue with your subscription on your favourite podcast App. Lupus Science and Medicine is a global, peer reviewed, Open Access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open Access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others. Contains tracks Biomarker reduction indicates treatment response to Belimumab by BMJ talk medicine published on 2023-05-18T14:59:54Z Mesenchymal stromal cells: a potential new SLE treatment option? by BMJ talk medicine published on 2022-08-02T10:26:21Z Using patient registries to estimate SLE incidence rate in the USA by BMJ talk medicine published on 2022-05-26T15:06:32Z Defining remission in systemic lupus erythematosus by BMJ talk medicine published on 2022-05-26T15:03:00Z What's the relationship between self-efficacy and quality of life in SLE patients? by BMJ talk medicine published on 2022-04-28T08:09:48Z
Biomarker reduction indicates treatment response to Belimumab by BMJ talk medicine published on 2023-05-18T14:59:54Z
Mesenchymal stromal cells: a potential new SLE treatment option? by BMJ talk medicine published on 2022-08-02T10:26:21Z
Using patient registries to estimate SLE incidence rate in the USA by BMJ talk medicine published on 2022-05-26T15:06:32Z
Defining remission in systemic lupus erythematosus by BMJ talk medicine published on 2022-05-26T15:03:00Z
What's the relationship between self-efficacy and quality of life in SLE patients? by BMJ talk medicine published on 2022-04-28T08:09:48Z
